Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan Duration for H. pylori Eradication
NCT05728424Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- Sep 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Aga Khan University. Primary endpoint: Efficacy of triple therapy in eradication of H.pylori at 6 months. Status: unknown.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05728424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05728424.